Monday, August 26, 2013

Dexa Medica launches new extract plant for herbal medicines in Indonesia - Pharmaceutical Business Review

PBR Staff Writer Published 26 August 2013

Indonesia-based PT Dexa Medica has rolled out its new production facility in Cikarang, West Java, to extract plants saps for herbal medicines.

Indonesia health minister Nafsiah Mboi was quoted by The Jakarta Post as saying, "Local private companies have started to develop the extract industry, which could facilitate the production of affordable herbal medicines."

"We want to encourage companies to take the initiative in developing our rich natural plant resources for herbal medicines by issuing Regulation No. 006/2012 on traditional medicines business and industry."

As per a study by the Indonesian Institute of Sciences (LIPI), Indonesia is home to nearly 30,000 out of 40,000 species of plants with medicinal properties in the world, making it the hub for herbal medicines research.

However, Indonesia imports plants extracts from China, India and Brazil, which is used to manufacture herbal medicine.

As per a data released by the country's health ministry, the market for Indonesian herbal medicines will touch Rp13trn ($1.2bn) during 2013.

Dexa Laboratories of Biomolecular Sciences executive director Raymond Tjandrawinata was quoted by the news portal as saying that the company has been focusing on development of natural ingredients as raw materials for herbal medicines, since its inception in 2005.

He further said that the firm developed five herbal medicines in tablet form, using natural ingredients such as cinnamon (Cinnamomum burmannii), mahkota dewa plant (Phaleria macrocarpa) and (Lagerstroemia speciosa).

"These plants have been scientifically proven to treat conditions like diabetes, high cholesterol, hypertension and endometriosis, which can cause symptoms like pelvic pain and irregular menstrual bleeding," he added.

Recent Articles